I can see the author's point of view, but this is a rare case (for me personally) that I am not in support of more government oversight.
[0] http://www.medtronicdiabetes.com/treatment-and-products/mini...
I can see the author's point of view, but this is a rare case (for me personally) that I am not in support of more government oversight.
[0] http://www.medtronicdiabetes.com/treatment-and-products/mini...
http://www.motherjones.com/kevin-drum/2013/10/heres-why-your...
The statistical result of the 1962 Amendments is that the beneficial effects of reducing the amount of bad drugs being released is far more outweighed by losing the beneficial effects of drugs being delayed or not being developed. But people only see the former.
This seems to be a trend, when people know about a certain field well, they are against the government oversight of it. The issue of course is that people are usually intimately familiar with maybe ONE field, but get an opinion on everything, and thus are very cautious of all the things they don't know anything about.
Software people understand the problems with "making encryption illegal", regular people don't and are more willing to hear the high level "safety issues" of letting hackers hide their information.
You are well aware of the issues with these devices, most people aren't and are more willing to hear the high level "safety issues" of letting any ol' device get into the hands of consumers.
Scientists know about all the potential benefits of stem cell research, most people without biology degrees are more willing to hear the high level "safety issues" of the frankenstein stories we're sold.
Because we have the "nutritional supplement" market as a working example of "We give people stuff without bothering to see if any of it actually works".
Or, even, if its actually the stuff that it claims to be, much less whether the stuff it claims to be works.
[0] see, e.g., http://well.blogs.nytimes.com/2015/02/03/new-york-attorney-g...
What pharmaceutical company is going to bother getting FDA approval for an already-patented substance that is dirt cheap and readily available?
In the EU, melatonin is regulated and requires a prescription -- which seems to me to be an unnecessary cost and hassle.
Presumably they are making a profit at it. They spent a bunch of money to set up factories to produce, package, and market melatonin, why suppose that FDA approval, but not these hurdles, would stop them?
Or what about the patent-holder (if there is one)? One would think they would have ample incentive to seek FDA approval if they have a temporary monopoly on producing the compound.
Clearly more hurdles are... more hurdles?
I guess I just don't see how this question isn't a tautology. No one is arguing that the other hurdles couldn't stop it either. But if the manufacturing costs are $1 million, and the FDA costs are $1 million, then I don't see how it isn't obvious that needing BOTH is $2 million and thus MUCH more difficult. I agree that if we could magically reduce manufacturing costs to zero it would be even better. But your argument literally seems to be "since this is already expensive and difficult, we can make it arbitrarily more expensive and difficult with no reduction in success rate". Which obviously isn't true. More to the point: we know that it can get through the manufacturing hurdles because it did. We thus know this company is capable of 1x costs. Had they ALSO had additional costs from the FDA then it would have been >1x costs and thus we don't know if they would have succeeded.
Perhaps an analogy. Let's say someone proposed a new fee for graduating college of $50,000. I would say "well, that might make it so less people can graduate, since it'll cost more". Then you might respond "But what makes you think THIS cost will prevent them, and not the existing expensive tuition?". Well, both do, but they already pay one and we're in control of a theoretical second one.
> Or, perhaps more to the point, why this particular hurdle is not worth the supposed consumer protection benefits of FDA regulation?
This on the other hand is a completely reasonable question, but not more to the point, just a a compeletely different point than "the company already has costs, what is the problem with more costs?"
Presumably they would not if they had to fund an arduous regulatory adventure while competing in a market against unregulated peers.
I think the best we could hope for here is that the USDA or some independent lab might test & certify that a bottle of melatonin contains what it says it contains, without respect to the safety or efficacy of melatonin.
There are two dangers: letting a bad device into use, and preventing a good device from entering use. And both "good" and "bad" are relative here, so it's a tricky dance. Personally, I thought the FDA was doing about right. They forced us to really have all our ducks in a row, but that's actually appropriate.
But with all that said, I personally found it a horrible environment for an engineer to try to live in, and I got out.
Its interesting that SV is often criticized for not taking on these "big important problems", but at the same time these are markets that can be impenetrable given that the entire fate of the company can be in limbo for years during approval, requiring tremendous up front investment that is harder to predict.
True. Management mentioned it from time to time, as a barrier to entry for competitors.
I worked for a company that made an FDA approved diagnostic device. And to be clear, for the condition it targeted, an incorrect diagnosis would kill. The approval was slow, expensive, and cumbersome. I absolutely support it. Consider the average code quality you see with every piece of software you touch. Hell, even apple can't update their iphones -- with very few models to test -- without killing wireless on some of them. The FDA required that your code was tested so that given certain inputs, it produced correct outputs every single time, and documentation to that effect.
I wish we could speed the process up, but I think it's the best alternative we have going.
edit: this was my first serious dev job. They didn't use source control. "source control" was a random computer holding the master copy; after a month or two of development, you'd spend a couple days merging your code into the master copy then copy the merged codebase to your desktop. All 8 devs did this. There were wild merge problems, as you can imagine with that much divergence. "History tracking" was copying the entire directory structure to a series of labeled directories.
There were two ways to license the machines: one for human testing (with fda approval), and one for non-human testing. The latter got releases every 3-6 mos. One at least one occasion, code was shipped so broken that it conclusively proved it had never been successfully run, not even once. The "deploy" process was to copy code from the master server, hit build in visual studio, and burn that to cds.
Automated tests? What are those? Test suites were run instructions written in a spiral notebook. (To be fair, it's hard to work with bio samples.)
I wrote a bunch of code that basically mocked the device by installed a special driver that replayed saved data files. I wrote this on my own time so I could occasionally work from home without lugging a giant contaminated machine back and forth. I shared it with coworkers and it eventually made its way to the testing lab on the other side of the country without my knowledge. When I quit, I deleted all source code. It turns out they hadn't kept a copy of this driver and frantically contacted me several months after I left when an embedded system upgrade broke it.
Many of these are symptoms of a company run by bio scientists who viewed engineering as a cost center and barely even a real career. There are lots of companies like this.
But that's not always the case, it's not even the average case. Where there is much lower risk, there should be much lower barrier to entry. Treating every medical device as if it were a likely Therac-25 is not even remotely a good solution, and in some of these cases the lack of approved medical equipment is directly contributing to many peoples' untimely deaths, and to even more peoples' poor-health and/or poor quality of life.